Rationale and Design of the HeartShare/AMP-HF Deep Phenotyping Study to Improve Understanding of Heart Failure With Preserved Ejection Fraction.

Saved in:
Bibliographic Details
Title: Rationale and Design of the HeartShare/AMP-HF Deep Phenotyping Study to Improve Understanding of Heart Failure With Preserved Ejection Fraction.
Authors: Borlaug BA; Mayo Clinic, Rochester, Minnesota, USA. Electronic address: Borlaug.Barry@mayo.edu., Chirinos JA; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Lewis GD; Massachusetts General Hospital, Boston, Massachusetts, USA., Redfield MM; Mayo Clinic, Rochester, Minnesota, USA., Bertoni AG; Wake Forest University School of Medicine, Winston Salem, North Carolina, USA., Cadeiras M; University of California Davis, Sacramento, California, USA., Chiamvimonvat N; University of California Davis, Sacramento, California, USA; University of Arizona College of Medicine, Phoenix, Arizona, USA., Desai AS; Brigham and Women's Hospital, Boston, Massachusetts, USA., Givertz MM; Brigham and Women's Hospital, Boston, Massachusetts, USA., Kass DA; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Khan SS; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Kitzman DW; Wake Forest University School of Medicine, Winston Salem, North Carolina, USA., López JE; University of California Davis, Sacramento, California, USA., Rasmussen-Torvik LJ; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Sharma K; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Solomon SD; Brigham and Women's Hospital, Boston, Massachusetts, USA., Goodpaster B; AdventHealth Research Institute, Orlando, Florida, USA., Sparks L; AdventHealth Research Institute, Orlando, Florida, USA., Olgin J; University of California-San Francisco, San Francisco, California, USA., Arnaout R; University of California-San Francisco, San Francisco, California, USA., Mylavarapu U; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Alagna L; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Luo Y; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Wong R; Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA., Desvigne-Nickens P; Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA., Tinsley E; Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA., Kamphaus TN; Foundation for the National Institutes of Health, North Bethesda, Maryland, USA., Taylor JL; Foundation for the National Institutes of Health, North Bethesda, Maryland, USA., Jones MA; Foundation for the National Institutes of Health, North Bethesda, Maryland, USA., Jessup M; American Heart Association, Dallas, Texas, USA., Schaper S; Bayer Pharmaceuticals, Leverkusen, Germany., Chutnow WA; Novartis Biomedical Research, Cambridge, Massachusetts, USA., Shah SH; Duke Clinical Research Institute, Chapel Hill, North Carolina, USA., Butler J; Baylor Scott and White Research Institute, Dallas, Texas, USA; University of Mississippi, Jackson, Mississippi, USA., Sachdev V; Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA., Shah SJ; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Source: JACC. Heart failure [JACC Heart Fail] 2025 Dec; Vol. 13 (12), pp. 102714.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101598241 Publication Model: Print Cited Medium: Internet ISSN: 2213-1787 (Electronic) Linking ISSN: 22131779 NLM ISO Abbreviation: JACC Heart Fail Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2213-1787
DOI:10.1016/j.jchf.2025.102714